Neurology · 2026 so far

FDA-cleared AI devices for neurology 2026

2026 is still in progress (FDA decisions through June 29, 2026): 8 neurology AI devices so far, against 19 in all of 2025. That is 11% of the 73 neurology devices on the FDA list, and 4.4% of all AI-device decisions dated 2026. The most active were Medtronic Navigation, Inc. (2), Alphatec Spine, Inc. (1), Earlitec Diagnostics (1). The newest is SOMNUM (SOMNUM) from Honeynaps Co., Ltd., decided on June 27, 2026.

82026 devices
7Companies
4.4%Of all 2026 AI devices
11%Of all neurology

By month

Jan: 1Feb: 1Mar: 3Apr: 1May: 0Jun: 2
JanFebMarAprMayJun
Neurology AI devices by month in 2026: Jan 1, Feb 1, Mar 3, Apr 1, May 0, Jun 2

All 8 devices

Frequently asked questions

How many FDA-cleared AI neurology devices were there in 2026?

Through June 29, 2026, 8 AI-enabled neurology devices have a 2026 decision. That is 11% of all 73 neurology devices on the list.

How does 2026 compare with 2025 for AI neurology devices?

2026 is still in progress (FDA decisions through June 29, 2026): 8 neurology AI devices so far, against 19 in all of 2025.

Which companies cleared the most AI neurology devices in 2026?

Medtronic Navigation, Inc. (2), Alphatec Spine, Inc. (1), Earlitec Diagnostics (1).

What was the most recent AI neurology device in 2026?

SOMNUM (SOMNUM) from Honeynaps Co., Ltd. (K253390), decided on June 27, 2026. Product code OLZ.

Which product codes were most common for AI neurology devices in 2026?

OLZ (Automatic Event Detection Software For Polysomnograph With Electroencephalograph): 2; GWF (Stimulator, Electrical, Evoked Response): 1; GXY (Electrode, Cutaneous): 1.

Cite as: AI Device Radar, “FDA-cleared AI devices for neurology 2026,” https://ai-device-radar.vercel.app/specialty/neurology/2026 (FDA list through 2026-06-29).